Selected Problems of Malaria Blood Stage Immunity

Tokai Journal of Experimental and Clinical Medicine

Volumn 23, Issue 2, 1998, Pages 35-62

  Perlmann, Peter ^a   Perlmann, Hcdvig ^a   Berzins, Klavs ^a   Troye Blomberg, Marita ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; PARASITE ANTIGEN; PROTOZOON ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BLOOD; CELLULAR IMMUNITY; GENETICS; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; MOUSE; PARASITOLOGY; PATHOGENICITY; PLASMODIUM FALCIPARUM; REVIEW; SECRETION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; HOST-PARASITE RELATIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; MALARIA, FALCIPARUM; MICE; PLASMODIUM FALCIPARUM; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032035341     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Baird J K., 1995. Host age as a determinant of naturally acquired immunity to Plasmadium falciparum. Parasitol Today 11:105-111.
2. Anders R. F., 1986. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria with special reference to oxidant stress Parasite Immunol. 8:529-539
3. Walliker D., 1994. The role of molecular genetics in field studies on malaria parasites Int. J Parasitol. 24:799-808
4. Hill A. V. S., Allsopp C. E. M., Kwiatkowski D., Anstey N. M., Twumasi P., Rowe P. A., Bennett S., Brewster D , McMichael A. J and Greenwood B. M., 1991. Common West African HLA antigens are associated with protection from severe malaria, Nature 352:595-600.
5. Sjöberg K., Lepers J P., Raharimalala L., Larsson Å., Olerup O., Marbian N. T., Troye-Blomberg M. and Perlmann P., 1992. Genetic regulation of human anti-malarial antibodies in twins. Proc. Natl. Acad. Sci. USA 89:2101-2104.
6. Jepson A., Banya W., Sisay-Joof F., Hassan-King M., Nunes C., Bennett S. and Whittle H, 1997. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens Infect. Immunity 65:872-876.
7. Modiano D., Petrarca V., Sirima B. S , Nebié I., Diallo D., Esposito F. and Coluzzi M , 1996. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc. Natl. Acad. Sci. USA 93:13206-13211.
8. Modiano D . Chiuchiuini A., Petrarca V., Sirima B S., Luoni G., Perlmann H, Esposito F. and Coluzzi M., 1997. Humoral response to Plasmodium falciparum. PFI55/RESA and Pf332 in three sympatric ethnic groups of Burkina Faso, West Africa. Am. J. Trop. Med. Hyg. in press.
9. Berzins K. and Perlmann P., 1996. Malaria vaccines, attacking infected erythrocytes In Hoffman SL, ed. Malaria Vaccine Development A Multi-Immune Response Approach. American Society for Microbiology Press, Washington, DC, 105-143.
10. Reeder J. C. and Brown G. V., 1996. Antigenic variation and immune evasion in Plasmodium falciparum malaria. Immunol. Cell Biol. 74:546-554.
11. Wåhlin Flyg B., Perlmann H., Perlmann P., Esposito F. and Berzins K., 1997. Wild isolates of Plasmodium falciparum malaria show decreased sensitivity to in vitro inhibition of parasite growth mediated by autologous host antibodies. Clin. Exp. Immunol. 107:321-327.
12. Iqbal J., Siripoon N., Snounou G., Perlmann P. and Berzins K., 1997. Plasmodium falciparum: selection of parasite subpopulations with decreased sensitivity for antibody-mediated growth inhibition in vitro. Parasitol. 114:317-324
13. Mattei D. and Scherf A., 1992. The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes. Gene 110:71-79
14. Ahlborg N., Berzins K. and Perlmann P., 1991. Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2 Mol. Biochem. Parasitol. 46:89-96.
15. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsupha jaisiddhi T. and Druilhe P., 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633-1641.
16. Ho M., Tongtawe P., Kriangkum J. K., Wimouwattra-Watee T., Pattanapanyasat K., Bryant L., Shafiq J., Suntharsamal S., Loareesuwan S., Webster H. K. and Eliot J. F., 1994. Polyclonal expansion of peripheral γ/δ + T cells in human Plasmodium. falciparum malaria. Infect. Immunity 62:855-862.
17. Goodier M., Krause jauer M., Sanni A., Massougbod ji A., Sadeler B. C., Muchell G. H., Modolell M., Eichmann K. and Langhorne J., 1993. γ/δ -T cells in the peripheral blood of individuals from an area of holoendemic Plasmodium falciparum. transmission. Trans. Roy. Soc Trop. Med. Hyg. 87:692-696.
18. Roussilhon C., Agrapart M., Ballet J. J. and Bensussaan A., 1990. T lymphocytes bearing the γ/δ T cell receptor in patients with acute Plasmodium falciparum malaria. J. Infect. Dis. 162:283-285.
19. Perera M. K., Carter R., Goonewardene R. and Mendis K. M., 1994. Transient increase in circulating γ/δ T cells during Plasmodium vivax. malarial paroxysms. J. Exp. Med. 179:311-315.
20. - T cells stimulated by Plasmodium falciparum Parasite Immunol 17:413- 423
21. Tsuji M., Mombaerts P., Lefrancois L., Nussenzweig R. S., Zavala F. and Tonegawa S., 1994 γ/δ T cells contribute to immunity against the liver stages of malaria α β T-cell-deficient mice. Proc. Natl. Acad. Sci. USA 91:345-349
22. Elloso M. M., van der Heyde H. C., vande Waa J. A., Manning D. D. and Weidanz W. P., 1994, Inhibition of Plasmodium falciparum in vitro by human γ/δ T cells. J Immunol. 153:1187-1194.
23. Kaufmann S. H. E., 1996. γ/δ and other unconventional T lymphocytes: what do they see and what do they do? Proc. Natl. Acad. Sci. USA 93:2272-2279
24. Tanaka Y., Morita C. T., Tanaka Y., Nicoes E., Brenner M. B. and Bloom B. R., 1995. Natural and synthetic non-peptide antigens recognized by human γ/δ T cells. Nature 375:155-158.
25. Behr C., Poupot R., Peyrat M.-A., Poquet Y., Constant P., Dubois P., Bonneville M. and Fournie J.-J., 1996. Plasmodium falciparum stimuli for human γ/δ T cells are related to phosphorylated antigens of mycobacteria. Infect. Immun. 64:2892-2896.
26. Pichyangkul S., Saengkrai P., Yongvanitchit K., Stewart A. and Heppner D. G., 1997. Activation of γ/δ T cells in malaria: interaction of cytokines and a schizont-associated Plasmodium falciparum antigen. J. Infect. Dis. 176:233-241.
27. Hoffman S. L., Franke E. D., Hollingdale M. R. and Druilhe P., 1996. Attacking infected hepatocytes. In Hoffman, S. L., ed., Malaria Vaccine Development: A multi-immune response approach. American Society for Microbiology Press, Washington, DC, 35-75.
28. + T-cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J. Immunol 151:489-499.
29. Troye-Blomberg M. and Perlmann P., 1994. Malaria immunity, an overview with emphasis on T cell function. Good MF and Saul AJ, eds. Molecular Immunological Considerations in Malaria Vaccine Development. Boca Raton, Florida, USA: CRC Press, Inc., 1-46.
30. Mosmann T. R. and Coffman R. L., 1989. TH1 and TH2 cells- Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173
31. Del Prete G. F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M. and Romagnani S., 1991, Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (Type 1 T helper or Type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.
32. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279.
33. Abbas A. K., Murphy K. M. and Sher A., 1996. Functional diversity of helper T lymphocytes. Nature 787-793.
34. Romagnani S., 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
35. + T cells reactive with Plasmodium Chabudi chabaudx: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int. Immunol. 1:416-424
36. Stevenson M. M. and Tarn M. F., 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi as infection in resistant and susceptible mice. Clin. Exp. Immunol. 92:77-83.
37. Clark I. A., MacMicking J. D., Gray K. M., Rockett K. A. and Cowden W. B., 1992. Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum. Am. J. Pathol. 140:325-336.
38. + T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development J. Immunol. 143:2017-2023.
39. Perlmann H., Kumar S., Vinetz J. M., Kullberg M., Miller L. H. and Perlmann P., 1995. Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice. Infect. Immun. 63:3987-3993.
40. Desowitz R. S., 1989. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria Trans. Roy. Soc. Trop. Med. Hyg. 83:478-479.
41. Perlmann H., Helmby H., Hagstedt M., Carlson J., Larsson P. H., Troye-Blomberg M. and Perlmann P., 1994. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria' association of high IgE levels with cerebral malaria. Clin Exp Immunol. 97:284-292.
42. Helmby H, Perlmann H., Troye-Blomberg M. and Perlmann P., 1996. Immunoglobulm E elevation in Plasmodium chabaudi malaria. Infect. Immun. 64:1432-1433.
43. Finkelman F. D., Holmes J , Katona I M., Urban Jr. J. F., Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T R. and Paul W. E., 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
44. Zurawski G. and de Vries J. E , 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells but not on T cells. Immunol. Today 15:19-26.
45. ElGhazali G., Perlmann H., Rutta A. S M., Perlmann P. and Troye-Blomberg M., 1997. Elevated plasma levels of IgE in Plasmodium falaciparum-primed individuals reflect an increased ratio of IL-4 to interferon-gamma (IFN-γ)-producing cells. Clin. Exp. Immunol. 109:84-89.
46. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
47. Perlmann P., Perlmann H. and Troye-Blomberg M., 1996. IgE and TNF in malaria infection. Protection and pathogenicity: two sides of the same coin. The Immunologist 4/5:179-184.
48. Bonnefoy J. Y., Aubry J. P., Gauchat J. F., Graber P, Life P., Flores-Romo L. and Mazzei G., 1993. Receptors for IgE. Curr. Op. Immunol. 5:944-949.
49. Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfati M., Hofstetter H., Kilcherr E., Debré P. and Dalloul A , 1991 Expression, structure and function of the CD23 antigen. Adv. Immunol. 49:149-191.
50. Vercelli D., Jabara H. H., Lee B. W., Woodland N , Geha R. S. and Leung D. Y., 1988. Human recombinant interleukin 4 induces Fcε R2/CD23 on normal human monocytes. J. Exp. Med. 167:1406-1416.
51. Kawabe T., Takami M., Hosada M., Maeda Y., Sato S., Mayumi H., Mikawa M., Arai K. I. and Ydoi J., 1988. Regulation of Fcε R2/CD23 gene expression by cytokines and specific ligands (IgE and anti Fcε R2/CD23 monoclonal antibody). Variable regulation depending on cell types. J. Immunol. 141:1376-1382.
52. Voldoukis I., Issaly F., Fourcade C., Paul-Eugène N., Arock M., Kolb J. P., Alves da Suva O., Monjour L., Pouisot H., Tselentis Y., Dugas B., Debré P. and Mossalayi M. D., 1994. CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation. Res. Immunol. 145:17-27.
53. Dugas B., Mossalayi D., Damais C. and Kolb J. P., 1955. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 16:574-580.
54. Lecoanet-Henchoz S., Gauchat J. F., Aubry J. P., Graber P., Life P., Paul-Eugène N., Ferrua B., Corbi A. L., Dugas B., Plater-Zyberk C. and Bonnefoy J. Y , 1995 CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CDI1c-CD18. Immunity 3:119-125.
55. Perlmann P., Perlmann H., Flyg Wåhlin B., Hagstedt M., ElGhazali G., Worku S , Fernanda V., Rutta A. S. M. and Troye-Blomberg M., 1997. Immunoglobulin E., a pathogenic factor in Plasmodium falciparum malaria. Infect. Immun. 65:116-121.
56. Berendt A. R., Turner G. D. H. and Newbold C. I., 1994. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 10:412-414.
57. Clark I. A. and Rockett K. A., 1994 The cytokine theory of human cerebral malaria. Parasitol. Today 10:410-412.
58. Nussler A., Drapier J. C., Renia L., Pied S., Miltgen F., Gentilini M. and Mazier D., 1991. L-Arginne-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin-6 stimulation. Eur. J. Immunol. 21:227-230.
59. Kowanko I. C., Ferrante A , Clemente G. and Kumaratilake L. M., 1996. Tumor necrosis factor primes neutrophils to kill Staphylococcus aureus by an oxygen-dependent mechanism and Plasmodium falciparum by an oxygen-independent mechanism. Infect. Immun. 64:3435-3437.
60. Jacobs P., Radzioch D. and Stevenson M. M, 1996. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates wich resistance to blood-stage malaria in mica. Infect. Immun. 65:535-541.
61. Grau G E., Taylor T. E., Molyneux M. E., Virima J. J., Vassalli P., Hommel M. and Lambert P.-H., 1989. Tumor necrosis factor and disease severity in children with Plasmodium falciparum malaria. New Engl. J. Med. 320:1580-1591.
62. Shaffer N., Grau G E., Hedberg K., Davachi F , Lyamba B., Hightower A. W., Grennan J. G. and Nguyen-Dinh P., 1991. Tumor necrosis factor and severe malaria. J. Inf. Dis. 163:96-101.
63. McGuire W., Hill A. V., Allsopp C. E. M., Greenwood B. M. and Kwiatkowski D., 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511.
64. Kwiatkowski D., Hill A. V. S., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R. and Greenwood B. M., 1990. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204.
65. Kwiatkowski D., Molyneux M. E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D. R., Grau G. E. and Greenwood B. M., 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 86:91-98.
66. Pichyangkul S., Saengkrai P. and Webster H. K., 1994. Plasmodium falciparum pigment induces mono- cytes to release high levels of tumor necrosis factor-α and interleukin-1β. Am. J. Trop. Med. Hyg. 51:430-435.
67. Kwiatkowski D., 1995. Malarial toxins and the regulation of parasite density. Parasitol. Today 11:206-212
68. Bate C. A. W., Taverne J. and Playfair J. H. L., 1992. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect. Immun. 60:1894-1901.
69. Schofield L., Vivas L., Hackett F., Gerold P., Schwarz R T. and Tachado S., 1993. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-α-inducing toxin of Plasmodium falciparum' prospects for the immunotherapy of severe malaria. Ann. Trop. Med. Parasitol. 87/617-626.
70. Schofield L. and Tachado S. D., 1996. Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa. Immunol Cell Biol. 74:555-563.
71. Karunaweera N. D., Grau G. E., Garnage P., Carter R. and Mendis K. N., 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. USA 89:3200-3203.